Clinical trial
Olaparib and Radiotherapy in Inoperable Breast Cancer
NCT02227082
Study timeline
Study start (actual)2013-10-21Date precision: day
Registry last updated2021-08-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Locally Advanced Malignant Neoplasmunresolved
Inflammatory Breast Carcinomaunresolved
Interventions
radiotherapyRADIATION
olaparibDRUG · verified · RxNorm: olaparib
Sponsors & collaborators
The Netherlands Cancer Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02227082 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.